Statistiques de base
CIK | 1495850 |
SEC Filings
SEC Filings (Chronological Order)
May 20, 2014 |
g7424a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-5 |
|
May 20, 2014 |
ex10-1.htm Exhibit 10.1 |
|
November 4, 2013 |
Exhibit 10.1 Employment Contract This Agreement is made on the 5th of October 2013 Between: (1) Umicron Ltd. 08320701 whose registered office is 131 Terry Gardens, Kesgrave, Suffolk, IP5 2DR (“the Company”); and (2) Matthew Lummis of Wardens House, Butley, IP12 3NF (“the Employee”). Agreed terms 1. Interpretation 1.1 In this agreement the following terms shall have the following meanings: “Confide |
|
November 4, 2013 |
Exhibit 2.1 STOCK EXCHANGE AGREEMENT THIS STOCK EXCHANGE AGREEMENT (the “Agreement”) is made this 29th day of October, 2013 by and among Maksim 3D Corp., f/k/a Advanced Cellular, Inc., a Nevada corporation (“Pubco”) on one hand, and Umicron Ltd., a private limited company organized under the laws of England and Wales (the “Company”) and the shareholders of the Company as set forth on Exhibit A att |
|
November 4, 2013 |
8-K 1 g7133.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 29, 2013 Date of Report (Date of earliest event reported) Makism 3D Corp. (Exact Name of Registrant as Specified in Charter) Nevada 000-54222 42-1771506 (State or other jurisdiction of (Commission File (IRS Em |
|
November 4, 2013 |
Exhibit 10.4 PROPOSED FINANCING OF ADVANCED CELLULAR, INC. By reading the information contained within this document, the recipient agrees with Advanced Cellular, Inc. (the “Company”) to maintain in confidence such information, together with any other non-public information regarding the Company obtained from the Company or its agents during the course of the proposed financing. The Company has ca |
|
November 4, 2013 |
Exhibit 99.1 Umicron Ltd. (A Development Stage Company) August 31, 2013 Index to the Financial Statements Contents Page(s) Report of Independent Registered Public Accounting Firm F-2 Balance Sheet at August 31, 2013 F-3 Statement of Operations for the Period from December 6, 2012 (Inception) to August 31, 2013 F-4 Statement of Stockholders’ Equity (Deficit) for the Period from December 6, 2012 (In |
|
November 4, 2013 |
Exhibit 99.2 MAKISM 3D CORP. (f/k/a ADVANCED CELLULAR, INC.) Pro-Forma Combined Financial Statements UMICRON LTD. INTRODUCTION AND BASIS OF PRESENTATION FOR PRO FORMA COMBINED FINANCIAL STATEMENTS The following pro forma combined financial statements give effect to the acquisition of Umicron Ltd. (“Umicron”) by Makism 3D Corp. (“Makism”) by Share Exchange Agreement dated October 29, 2013, Makism a |
|
November 4, 2013 |
Exhibit 10.2 Employment Contract This Agreement is made on the 5th of October 2013 Between: (1) Umicron Ltd. 08320701 whose registered office is 131 Terry Gardens, Kesgrave, Suffolk, IP5 2DR (“the Company”); and (2) Luke Ruffell of 131 Terry Gardens, Kesgrave, Suffolk, IP5 2DR (“the Employee”). Agreed terms 1. Interpretation 1.1 In this agreement the following terms shall have the following meanin |
|
November 4, 2013 |
Exhibit 10.3 Employment Contract This Agreement is made on the 5th of October 2013 Between: (1) Umicron Ltd. 08320701 whose registered office is 131 Terry Gardens, Kesgrave, Suffolk, IP5 2DR (“the Company”); and (2) Feroz Khan of 65 Hornbeam Road, Theydon Bois, CM16 7JU (“the Employee”). Agreed terms 1. Interpretation 1.1 In this agreement the following terms shall have the following meanings: “Co |